UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

Trends in pharmacological sciences (Regular ed.), 2004-08, Vol.25 (8), p.430-436

2004

Volltextzugriff (PDF)

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640

2010

Volltextzugriff (PDF)

Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640-6652

2010

Volltextzugriff (PDF)

Molecular hybridization yields triazole bronchodilators for the treatment of COPD

Bioorganic & medicinal chemistry letters, 2015-11, Vol.25 (22), p.5121-5126

2015

Volltextzugriff (PDF)

SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4471-4475

2009

Volltextzugriff (PDF)

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

Bioorganic & medicinal chemistry letters, 2011-05, Vol.21 (9), p.2759-2763

2011

Volltextzugriff (PDF)

SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4471

2009

Volltextzugriff (PDF)

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease

Journal of medicinal chemistry, 2011-10, Vol.54 (19), p.6888-6904

2011

Volltextzugriff (PDF)

Inhalation by Design: Novel Ultra-Long-Acting β 2 -Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Journal of medicinal chemistry, 2010-09, Vol.53 (18), p.6640-6652

2010

Volltextzugriff (PDF)

Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells

Journal of cellular physiology, 1982-01, Vol.110 (1), p.9-16

1982

Volltextzugriff (PDF)

SAR of a series of inhaled A sub(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4471-4475

2009

Volltextzugriff (PDF)

Inhaled adenosine A sub(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

Inhaled adenosine A 2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (4), p.1284-1287

2008

Volltextzugriff (PDF)

Acute indomethacin-induced jejunal injury in the rat: Early morphological and biochemical changes

Gastroenterology (New York, N.Y. 1943), 1994-03, Vol.106 (3), p.567-575

1994

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: Underlying pathological mechanisms

General Pharmacology, 1995-11, Vol.26 (7), p.1455-1459

1995

Volltextzugriff (PDF)

THE β3-ADRENOCEPTOR AGONIST CL316243 PREVENTS INDOMETHACIN-INDUCED JEJUNAL ULCERATION IN THE RAT BY REVERSING EARLY VILLOUS SHORTENING

The Journal of pathology, 1996-07, Vol.179 (3), p.340-346

1996

Volltextzugriff (PDF)

5-Carboxamidotryptamine: A potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava

Life sciences (1973), 1986-04, Vol.38 (16), p.1521-1528

1986

Volltextzugriff (PDF)

Myosin Phosphorylation and Cyclic Adenosine 3′,5′-Monophosphate in Relaxation of Arterial Smooth Muscle by Vasodilators

Circulation research, 1984-01, Vol.54 (1), p.83-89

1984

Volltextzugriff (PDF)

5-hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro

Life sciences (1973), 1984-07, Vol.35 (5), p.477-486

1984

Volltextzugriff (PDF)

5-hydroxytryptamine-induced relaxation of neonatal porcine vena cava [formula omitted]

Life sciences (1973), 1984, Vol.35 (5), p.477-486

1984

Volltextzugriff (PDF)

Monoamine oxidase activities of porcine vascular endothelial and smooth muscle cells

Biochemical pharmacology, 1981-08, Vol.30 (16), p.2209-2216

1981

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Animals
(19)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Pharmacology & Pharmacy
(13)
Biological And Medical Sciences
(11)
Medical Sciences
(9)
Chemistry, Medicinal
(8)
Humans
(8)
Pharmacology. Drug Treatments
(8)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(7)
Rats
(7)
Administration, Inhalation
(6)
In Vitro Techniques
(6)
Swine
(6)
Chemistry
(5)
Chemistry, Organic
(5)
Guinea Pigs
(5)
Physical Sciences
(5)
Bronchodilator Agents - Pharmacology
(4)
Cho Cells
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup

Inhalation by Design: Novel Ultra-Long-Acting β2-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Molecular hybridization yields triazole bronchodilators for the treatment of COPD

SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Inhaled adenosine A2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

Inhalation by Design: Novel Tertiary Amine Muscarinic M 3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease

Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease

Inhalation by Design: Novel Ultra-Long-Acting β 2 -Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells

Optimized glucuronidation of dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD

SAR of a series of inhaled A sub(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

Inhaled adenosine A sub(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease

Inhaled adenosine A 2A receptor agonists for the treatment of chronic obstructive pulmonary disease

Acute indomethacin-induced jejunal injury in the rat: Early morphological and biochemical changes

Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: Underlying pathological mechanisms

THE β3-ADRENOCEPTOR AGONIST CL316243 PREVENTS INDOMETHACIN-INDUCED JEJUNAL ULCERATION IN THE RAT BY REVERSING EARLY VILLOUS SHORTENING

5-Carboxamidotryptamine: A potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava

Myosin Phosphorylation and Cyclic Adenosine 3′,5′-Monophosphate in Relaxation of Arterial Smooth Muscle by Vasodilators

5-hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro

5-hydroxytryptamine-induced relaxation of neonatal porcine vena cava [formula omitted]

Monoamine oxidase activities of porcine vascular endothelial and smooth muscle cells

Suchergebnisse filtern